A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone.

Papagikos MA, Rossi PJ, Urbanic JJ, deGuzman AF, McCullough DL, Clark PE, Lee WR
Am J Clin Oncol. 2007 30 (2): 199-204

PMID: 17414471 · DOI:10.1097/01.coc.0000251402.85009.af

MeSH Terms (18)

Aged Aged, 80 and over Analysis of Variance Biopsy Brachytherapy Cohort Studies Follow-Up Studies Humans Male Middle Aged Models, Statistical Multivariate Analysis Neoplasm Staging Predictive Value of Tests Prostate-Specific Antigen Prostatic Neoplasms Radiotherapy Dosage Recurrence

Connections (1)

This publication is referenced by other Labnodes entities: